Blood & Marrow Stem Cell Transplantation: Related News

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

Sergio Giralt, Chief of Memorial Sloan-Kettering’s Adult Bone Marrow Transplant Service, has been recognized for his achievements in the field of bone marrow transplantation with an award presented by GMA’s Robin Roberts.

Memorial Sloan-Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Researchers examined how changes in the microbiota may make patients more susceptible to severe infections and other complications.

In an interview, experts on our Adult Bone Marrow Transplantation Service talk about the types of transplantation and finding an appropriate donor for an allogeneic transplant.

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

“This is a celebration about your journey to return to the life you want to have,” Adult Bone Marrow Transplant Center Chief Sergio Giralt told 200 survivors at a party packed with friends and caregivers.

Memorial Sloan-Kettering medical oncologist Katharine C. Hsu and colleagues have described an immune benefit of allogeneic, or donor-provided, blood stem cell transplants in patients being treated for leukemia.